HIV-infection/Aids Clinical Trial
Official title:
HIV Risk Reduction Among Young Incarcerated Females
This project assesses the efficacy of an HIV prevention program with adolescent females incarcerated in the Mississippi training school for girls. Participants in both the health education control group and the HIV prevention group will increase health knowledge as a result of their participation in the health classes while incarcerated. However, participants in the HIV prevention group will increase their condom application, assertiveness, and communication skills relative to girls in the health education only group. In addition, after release from the training school, participants in the HIV prevention group will report lower sexual risk behaviors and will have lower rates of infection with chlamydia and gonorrhea during the 12-month follow-up period than participants in the health education only group.
This study is a longitudinal analysis of STD/HIV exposure among adolescent female offenders
in Mississippi, a population that is disproportionately African American, and at higher risk
than adolescents in general due to their propensity to engage in a variety of risk-taking
behaviors, earlier onset of sexual behaviors, and the greater prevalence of mental
disorders, substance abuse disorders, maltreatment, and family dysfunction. Based on social
cognitive theory and Fisher and Fisher's (1992) IMB (Information, Motivation, and Behavioral
skills) model, we will evaluate a drug abuse related HIV risk reduction intervention and
compare outcomes against a STD/HIV information and health education control condition.
Approximately 400 females committed to the state reformatory/training school for girls will
be recruited for participation. The research design will consist of alternating cohort/waves
of about 50 subjects each. One treatment condition will be administered at a time with a
washout period between cohort/waves. Over a three year period, one half of subjects will get
18 hours of STD/HIV prevention and one half will get 18 hours of Health Education. All
subjects will receive one individual counseling session designed to enhance motivation for
behavioral change just prior to release from training school. Before and after the
intervention, subjects' social competency skills, condom application skills, and health
knowledge will be measured. Before intervention and at 6-month and 12-month follow-up,
self-report measures of alcohol and drug use, condom use, sexual risk behaviors, and
measures of victimization, partner risk, condom attitudes, self-efficacy, and communication
related to condom use and risk reduction will be collected. Urine tests for the detection of
2 STDs (chlamydia and gonorrhea) will also be performed at admission to Columbia Training
School and at 6-month and 12-month follow-up.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03403569 -
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
|
Phase 3 | |
Completed |
NCT02433743 -
Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA
|
N/A | |
Recruiting |
NCT02753049 -
Adherence Connection for Counseling, Education, and Support
|
N/A | |
Completed |
NCT01360762 -
Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
|
Phase 3 | |
Recruiting |
NCT03147859 -
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
|
Phase 2 | |
Recruiting |
NCT04297488 -
Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection
|
N/A | |
Completed |
NCT01827540 -
Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
|
Phase 1 | |
Completed |
NCT01475890 -
Vitamin D Supplementation in HIV
|
Phase 2/Phase 3 | |
Recruiting |
NCT05947539 -
Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention
|
N/A | |
Withdrawn |
NCT01442428 -
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
Phase 2/Phase 3 | |
Completed |
NCT02496793 -
Community-Based Peer Facilitator Intervention (Zimbabwe)
|
N/A | |
Completed |
NCT03069235 -
Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program
|
N/A | |
Completed |
NCT03794648 -
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
|
N/A | |
Withdrawn |
NCT04183738 -
Inflammation and Co-Infections in D²EFT
|
Phase 4 | |
Enrolling by invitation |
NCT03919695 -
Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda
|
N/A | |
Recruiting |
NCT04215926 -
NAFLD in HIV-infected Patients
|
||
Completed |
NCT01406626 -
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
|
N/A | |
Completed |
NCT04371835 -
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings
|
||
Completed |
NCT01140633 -
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
|
N/A | |
Enrolling by invitation |
NCT04373551 -
WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)
|
N/A |